2025 HCPCS Code Q5131
Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
| Notice | HCPCS Q5131 terminated on December 31, 2024. |
| Short Description | Inj, idacio, 20 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | July 01, 2023 |
| HCPCS Action Effective Date | January 01, 2025 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4189 - Artacent ac, 1 mg
- Q4190 - Artacent ac 1 sq cm
- Q4191 - Restorigin 1 sq cm
- Q4192 - Restorigin, 1 cc
- Q4193 - Coll-e-derm 1 sq cm
- Q4194 - Novachor 1 sq cm
- Q4195 - Puraply 1 sq cm
- Q4196 - Puraply am 1 sq cm
- Q4197 - Puraply xt 1 sq cm
- Q4198 - Genesis amnio membrane 1sqcm
- Q4199 - Cygnus matrix, per sq cm
- Q4200 - Skin te 1 sq cm
- Q4201 - Matrion 1 sq cm
- Q4202 - Keroxx (2.5g/cc), 1cc
- Q4203 - Derma-gide, 1 sq cm
- Q4204 - Xwrap 1 sq cm
- Q4205 - Membrane graft or wrap sq cm
- Q4206 - Fluid flow or fluid gf 1 cc
- Q4208 - Novafix per sq cm
- Q4209 - Surgraft per sq cm